Introducing our Early Stage Strategy service

Blue Latitude Health|20th February 2020

Blue Latitude Health introduces our new Early Stage Strategy service, designed to align commercial and medical teams and emphasise the value of the product for the patient, healthcare professional and business from the early phases of drug development.

To learn more about the service - click on the one-pager below and contact mark.assenti@bluelatitude.com

 

Our content has moved

Blue Latitude Health|18th November 2020

We’re posting all new articles on our parent website fishawack.com

read more

Fishawack Health launches Delta Magazine

Blue Latitude Health|17th November 2020

Our parent company Fishawack Health has launched a new magazine with a first issue unpacking rare disease.

read more

In the precision medicine era, the line between products and services is blurred

Amit Sheinholtz and Ilektra Safari|27th August 2020

Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?

read more